The new year has already passed and surely one of the goals many have made was to start at the gym to perceive this athletic body. However, not everyone believes it physical exercises can get rid of it " stomach "
However, there is nothing beyond the truth of the belief that physical exercises can not lower the abdomen. This is determined by a team of scientists from the University of Copenhagen.
According to his study, published in the journal Cell metabolism , a molecule called interleukin-6 (included in the inflammatory response) played a key role in the process.
In laboratory tests, a decrease in visceral abdominal fat was found in a group of obese adults who practiced bicycle exercises for twelve weeks, writes Hypertext.
It was also shown that men treated with tocilizumab, a remedy for rheumatoid arthritis, had an effect opposite to fat and even increased levels of cholesterol independent of physical activity.
"We all know that the exercise promotes better health, but now we are aware that regular training reduces the fat of the stomach and therefore potentially the risk of developing cardiometabolic diseases," explained Ana-Sophie Vedel-Neergard, the first author of the study.
Therefore, exercise and physical activity will reduce visceral fatty tissue, which surrounds the internal organs of the abdominal cavity, which is associated with a greater likelihood of cancer, dementia and mortality.
To reach these conclusions, the scientists analyzed this effect in 53 participants, divided into groups. One of these groups was exposed tocilizumab versus another with a saline solution such as placebo.
In addition, the groups were also exposed to a routine exercise exercise and had no routine exercise to make comparisons.
It has been shown that in placebo groups, exercise reduces visceral fat mass by 225 grams on average (8%), compared to those who did not participate in any sport.
analyzed in 53 participants the effect of tocilizumab against a saline solution such as placebo, in combination without physical activity or cycling routine. They used magnetic resonance imaging to evaluate the mass of visceral fat at the start and end of the study.
In placebo groups, exercise reduced visceral fat mass by 225 grams by an average (by 8%) compared to non-sports. However, treatment with tocilizumab eliminated this effect.
In exercise groups, tocilizumab also increased the visceral fat mass by approximately 278 grams compared to placebo. In addition, total and "bad" cholesterol (LDL, low density lipoprotein) have increased compared to placebo, both in exercises and groups that are not exercised.
"As far as we know, this is the first study to show that interleukin-6 has a physiological role in regulating visceral fat mass in humans," Vedel-Neergard added.
"When you start to exercise, you can even increase your body weight due to an increase in muscle mass. To stay motivated, in addition to weight calculation, it would be useful – and perhaps more importantly – to measure the waist circumference to follow loss of visceral fat, "the expert concludes.
Previous research mentioned adrenaline as responsible for this metabolism, but experts at the University of Copenhagen doubted that interleukin-6, because it regulates energy metabolism, stimulates fracture of fats in healthy people and is cleared of skeletal muscles during exercise.